Parita Bhuva, MD | |
1600 Coit Rd, Suite 104, Plano, TX 75075-6174 | |
(972) 566-5411 | |
(972) 519-8337 |
Full Name | Parita Bhuva |
---|---|
Gender | Female |
Speciality | Neurology |
Experience | 18 Years |
Location | 1600 Coit Rd, Plano, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164669701 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | N0649 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical City Plano | Plano, TX | Hospital |
Medical City Fort Worth | Fort worth, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Texas Stroke Center, Pllc | 6709927528 | 11 |
News Archive
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
People with a certain form of inherited hearing loss have increased sensitivity to low frequency vibration, according to a study by Professor Thomas Jentsch of the Leibniz-Institut f-r Molekulare Pharmakologie (FMP)/Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), conducted in cooperation with clinicians from Madrid, Spain and Nijmegen, the Netherlands.
› Verified 4 days ago
Entity Name | North Texas Stroke Center, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851624027 PECOS PAC ID: 6709927528 Enrollment ID: O20091230000483 |
News Archive
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
People with a certain form of inherited hearing loss have increased sensitivity to low frequency vibration, according to a study by Professor Thomas Jentsch of the Leibniz-Institut f-r Molekulare Pharmakologie (FMP)/Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), conducted in cooperation with clinicians from Madrid, Spain and Nijmegen, the Netherlands.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Parita Bhuva, MD 1600 Coit Rd, Suite 104, Plano, TX 75075-6174 Ph: (972) 566-5411 | Parita Bhuva, MD 1600 Coit Rd, Suite 104, Plano, TX 75075-6174 Ph: (972) 566-5411 |
News Archive
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.
Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
People with a certain form of inherited hearing loss have increased sensitivity to low frequency vibration, according to a study by Professor Thomas Jentsch of the Leibniz-Institut f-r Molekulare Pharmakologie (FMP)/Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), conducted in cooperation with clinicians from Madrid, Spain and Nijmegen, the Netherlands.
› Verified 4 days ago
John Nichalos Kamphaus, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1700 Alma Dr, Suite 480, Plano, TX 75075 Phone: 972-422-2008 Fax: 972-422-4014 | |
Paul Adrian Hansen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1600 Coit Rd, Suite 104, Plano, TX 75075 Phone: 972-566-5411 Fax: 972-519-8337 | |
Baer Max Ackerman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1700 Alma Dr, Suite 480, Plano, TX 75075 Phone: 972-422-2008 Fax: 972-422-4014 | |
Dr. Saadat Ali Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4001 W 15th St Ste 375, Plano, TX 75093 Phone: 972-200-1272 Fax: 972-890-9159 | |
Rishi A Patel, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6404 International Pkwy Ste 1010, Plano, TX 75093 Phone: 972-267-1988 | |
Nancy D Donachie, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1820 Preston Park Blvd Ste 2500, Plano, TX 75093 Phone: 972-733-7242 Fax: 972-733-7257 | |
Husnain Ashraf, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3447 Renner Rd Ste 120, Plano, TX 75074 Phone: 469-384-2989 |